Your institution may have access to this item. Find your institution then sign in to continue.
Title
Low-dose naltrexone therapy improves active Crohn's disease.
Authors
Smith, Jill P; Stock, Heather; Bingaman, Sandra; Mauger, David; Rogosnitzky, Moshe; Zagon, Ian S
Abstract
Endogenous opioids and opioid antagonists have been shown to play a role in healing and repair of tissues. In an open-labeled pilot prospective trial, the safety and efficacy of low-dose naltrexone (LDN), an opioid antagonist, were tested in patients with active Crohn's disease.
Publication
The American journal of gastroenterology, 2007, Vol 102, Issue 4, p820